Literature DB >> 30269230

Do Symptoms of Depression Interact with Substance Use to Affect HIV Continuum of Care Outcomes?

Anthony T Fojo1, Catherine R Lesko2, Keri L Calkins2, Richard D Moore3, Mary E McCaul3, Heidi E Hutton3, William C Mathews4, Heidi Crane5, Katerina Christopoulos6, Karen Cropsey7, Michael J Mugavero7, Kenneth Mayer8, Brian W Pence9, Bryan Lau2, Geetanjali Chander3.   

Abstract

Few studies examine how depression and substance use interact to affect HIV control. In 14,380 persons with HIV (PWH), we used logistic regression and generalized estimating equations to evaluate how symptoms of depression interact with alcohol, cocaine, opioid, and methamphetamine use to affect subsequent retention in care, maintaining an active prescription for ART, and consistent virologic suppression. Among PWH with no or mild depressive symptoms, heavy alcohol use had no association with virologic suppression (OR 1.00 [0.95-1.06]); among those with moderate or severe symptoms, it was associated with reduced viral suppression (OR 0.80 [0.74-0.87]). We found no interactions with heavy alcohol use on retention in care or maintaining ART prescription or with other substances for any outcome. These results highlight the importance of treating moderate or severe depression in PWH, especially with comorbid heavy alcohol use, and support multifaceted interventions targeting alcohol use and depression.

Entities:  

Keywords:  Alcohol; Depression; HIV; Illicit drug use; Viral suppression

Mesh:

Substances:

Year:  2019        PMID: 30269230      PMCID: PMC6408233          DOI: 10.1007/s10461-018-2269-0

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  95 in total

1.  Akaike's information criterion in generalized estimating equations.

Authors:  W Pan
Journal:  Biometrics       Date:  2001-03       Impact factor: 2.571

2.  Does alcohol intake affect highly active antiretroviral therapy (HAART) response in HIV-positive patients?

Authors:  P Fabris; G Tositti; V Manfrin; M T Giordani; A Vaglia; A M Cattelan; A Carlotto
Journal:  J Acquir Immune Defic Syndr       Date:  2000-09-01       Impact factor: 3.731

3.  Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users.

Authors:  Julia H Arnsten; Penelope A Demas; Richard W Grant; Marc N Gourevitch; Homayoon Farzadegan; Andrea A Howard; Ellie E Schoenbaum
Journal:  J Gen Intern Med       Date:  2002-05       Impact factor: 5.128

4.  Adherence to protease inhibitor therapy and outcomes in patients with HIV infection.

Authors:  D L Paterson; S Swindells; J Mohr; M Brester; E N Vergis; C Squier; M M Wagener; N Singh
Journal:  Ann Intern Med       Date:  2000-07-04       Impact factor: 25.391

5.  The PHQ-9: validity of a brief depression severity measure.

Authors:  K Kroenke; R L Spitzer; J B Williams
Journal:  J Gen Intern Med       Date:  2001-09       Impact factor: 5.128

6.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

7.  Does the presence of a current psychiatric disorder in AIDS patients affect the initiation of antiretroviral treatment and duration of therapy?

Authors:  Seth Himelhoch; Richard D Moore; Glenn Treisman; Kelly A Gebo
Journal:  J Acquir Immune Defic Syndr       Date:  2004-12-01       Impact factor: 3.731

8.  Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy.

Authors:  Ronald J Ellis; Meredith E Childers; Mariana Cherner; Deborah Lazzaretto; Scott Letendre; Igor Grant
Journal:  J Infect Dis       Date:  2003-12-08       Impact factor: 5.226

9.  Predictors of virologic failure and resistance in HIV-infected patients treated with nevirapine- or efavirenz-based antiretroviral therapy.

Authors:  Jean-Jacques Parienti; Véronique Massari; Diane Descamps; Astrid Vabret; Elisabeth Bouvet; Bernard Larouzé; Renaud Verdon
Journal:  Clin Infect Dis       Date:  2004-04-14       Impact factor: 9.079

10.  Co-occurring psychiatric symptoms and drug dependence or heavy drinking among HIV-positive people.

Authors:  Frank H Galvan; M Audrey Burnam; Eric G Bing
Journal:  J Psychoactive Drugs       Date:  2003-05
View more
  13 in total

1.  Effects of Two Alcohol Reduction Interventions on Depression and Anxiety Symptoms of ART Clients in Vietnam.

Authors:  M X Nguyen; H L Reyes; B W Pence; K E Muessig; H E Hutton; C A Latkin; D Dowdy; G Chander; K E Lancaster; C Frangakis; T Sripaipan; H V Tran; V F Go
Journal:  AIDS Behav       Date:  2021-11-22

2.  Psychiatric trajectories across adolescence in perinatally HIV-exposed youth: the role of HIV infection and associations with viral load.

Authors:  Nadia Nguyen; C Jean Choi; Reuben Robbins; Rehema Korich; Jeanette Raymond; Curtis Dolezal; Cheng-Shiun Leu; Andrew Wiznia; Elaine J Abrams; Claude A Mellins
Journal:  AIDS       Date:  2020-07-01       Impact factor: 4.177

3.  Assessing the interaction between depressive symptoms and alcohol use prior to antiretroviral therapy on viral suppression among people living with HIV in Rural Uganda.

Authors:  Jacklyn D Foley; Alan Sheinfil; Sarah E Woolf-King; Robin Fatch; Nneka I Emenyonu; Winnie R Muyindike; Allen Kekibiina; Christine Ngabirano; Jeffrey H Samet; Debbie M Cheng; Judith A Hahn
Journal:  AIDS Care       Date:  2020-06-01

4.  Antiretroviral prescription, retention in care and viral suppression by place of birth among adults with diagnosed HIV in the United States-2015-2017, medical monitoring project.

Authors:  Hanna B Demeke; Qingwei Luo; Linda Beer; John Weiser
Journal:  AIDS Care       Date:  2020-03-10

5.  Polysubstance use and adherence to antiretroviral treatment in the Miami Adult Studies on HIV (MASH) cohort.

Authors:  Abraham Degarege; Karl Krupp; Javier Tamargo; Sabrina Sales Martinez; Adriana Campa; Marianna Baum
Journal:  AIDS Care       Date:  2021-03-05

6.  HIV Infection and Depression Among Opiate Users in a US Epicenter of the Opioid Epidemic.

Authors:  Cecile M Denis; Tiffany Dominique; Peter Smith; Danielle Fiore; Yi-Chien Ku; Angus Culhane; Debora Dunbar; Dana Brown; Menvekeh Daramay; Chelsea Voytek; Knashawn H Morales; Michael B Blank; Paul F Crits-Christoph; Steven D Douglas; Serguei Spitsin; Ian Frank; Krystal Colon-Rivera; Luis J Montaner; David S Metzger; Dwight L Evans
Journal:  AIDS Behav       Date:  2021-01-15

7.  Longitudinal Associations of Syndemic Conditions with Antiretroviral Therapy Adherence and HIV Viral Suppression Among HIV-Infected Patients in Primary Care.

Authors:  Satyanand Satyanarayana; Brooke G Rogers; Sierra A Bainter; Katerina A Christopoulos; Rob J Fredericksen; William C Mathews; Richard D Moore; Michael J Mugavero; Sonia Napravnik; Adam W Carrico; Matthew J Mimiaga; Kenneth H Mayer; Heidi M Crane; Steven A Safren
Journal:  AIDS Patient Care STDS       Date:  2021-06       Impact factor: 5.944

8.  Depression and HIV viral nonsuppression among people engaged in HIV care in an urban clinic, 2014-2019.

Authors:  Catherine R Lesko; Heidi E Hutton; Anthony T Fojo; Nicola M Shen; Richard D Moore; Geetanjali Chander
Journal:  AIDS       Date:  2021-10-01       Impact factor: 4.632

9.  Trajectories of Self-Reported Opioid Use Among Patients With HIV Engaged in Care: Results From a National Cohort Study.

Authors:  E Jennifer Edelman; Yu Li; Declan Barry; Jennifer Brennan Braden; Stephen Crystal; Robert D Kerns; Julie R Gaither; Kirsha S Gordon; Ajay Manhapra; Jessica S Merlin; Brent A Moore; Benjamin J Oldfield; Lesley S Park; Christopher T Rentsch; Melissa Skanderson; Emily C Williams; Amy C Justice; Janet P Tate; William C Becker; Brandon D L Marshall
Journal:  J Acquir Immune Defic Syndr       Date:  2020-05-01       Impact factor: 3.771

10.  HIV Care Outcomes among Hispanics/Latinos with Diagnosed HIV in the United States by Place of Birth-2015-2018, Medical Monitoring Project.

Authors:  Hanna B Demeke; Qingwei Luo; Ruth E Luna-Gierke; Mabel Padilla; Gladys Girona-Lozada; Sandra Miranda-De León; John Weiser; Linda Beer
Journal:  Int J Environ Res Public Health       Date:  2019-12-25       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.